People who took statins to lower cholesterol were approximately 50% less likely to die if hospitalized for COVID-19.
Study analyzed data from electronic health records
Based on their observations, the authors looked at outcomes for 2,626 patients with COVID-19 who were admitted to a quaternary academic medical center in Manhattan during the first 18 weeks of the pandemic.
The researchers compared 648 patients who regularly used statins before developing COVID-19 to 648 patients who did not use statins. Patients in each group were matched so that there were no significant differences in demographics, comorbidities, or use of other medications at home. Nature Communications
Release date: 26 February 2021
Source: Columbia University Irving Medical Center